High prevalence of unusual KRAS , NRAS , and BRAF mutations in POLE <scp> ‐ </scp> hypermutated colorectal cancers-Reference-Cited by-同舟云学术

High prevalence of unusual KRAS , NRAS , and BRAF mutations in POLE ‐ hypermutated colorectal cancers

Published:2022-07-14 Issue:17 Volume:16 Page:3055-3065
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Favre Loetitia¹²^ORCID,Cohen Justine¹,Calderaro Julien¹²,Pécriaux Adrien¹,Nguyen Cong‐Trung²,Bourgoin Rémi¹,Larnaudie Laura¹,Dupuy Aurélie²,Ollier Marie¹,Lechapt Emmanuèle¹²,Sloma Ivan²³^ORCID,Tournigand Christophe²⁴,Rousseau Benoit⁴⁵,Pujals Anaïs¹²^ORCID

Affiliation:

1. Département de Pathologie AP‐HP, Centre Hospitalier Universitaire Henri Mondor Créteil France

2. INSERM, IMRB Univ Paris Est Creteil France

3. Département d'Hématologie Biologique AP‐HP, Centre Hospitalier Universitaire Henri Mondor Créteil France

4. Service d'Oncologie Médicale AP‐HP, Centre Hospitalier Universitaire Henri Mondor Créteil France

5. Mortimer B. Zuckerman Research Center Memorial Sloan Kettering Cancer Center New York NY USA

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13257

Reference36 articles.

1. Replicative DNA polymerase mutations in cancer

2. A panoply of errors: polymerase proofreading domain mutations in cancer

3. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance

4. TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma

5. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer;Annals of Oncology;2024-07